1 Answer
Ranbaxy, an India-based pharmaceutical company, agreed to delay release of its generic version of Lipitor until Nov. 30.
According to its website, Ranbaxy will have the exclusive right to sell its drug in the U.S. for six months.
Experts say when generic versions of these drugs make it to market, pharmaceutical companies could face billions in potential losses, while consumers could save tens of billions of dollars a year.
13 years ago. Rating: 0 | |
Top contributors in Uncategorized category
Unanswered Questions
fun886Net
Answers: 0
Views: 3
Rating: 0
Karachi Escorts
Answers: 0
Views: 5
Rating: 0
CEO Nam Nguyễn
Answers: 0
Views: 4
Rating: 0
U888ez com
Answers: 0
Views: 3
Rating: 0
HITCLUB wine
Answers: 0
Views: 5
Rating: 0
DK Tan
Answers: 0
Views: 7
Rating: 0
98winfootball
Answers: 0
Views: 4
Rating: 0
VNBET
> More questions...
Answers: 0
Views: 4
Rating: 0